Stocks / NASDAQ / ITUS Corporation

ITUS Corporation

Company Description

ITUS Corp. engages in the development, acquisition, and licensing emerging technology in the field of biotechnology. It focuses on platform called Cchek, a series of inexpensive non-invasive blood tests for the early detection of cancer, which is based on the body’s immunological response to the presence of a malignancy. The company was founded on November 5, 1982 and is headquartered in Los Angeles, CA. [Source: MarketWatch]

Company Website: